Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 9, p. 603, doi. 10.1038/sj.cgt.7700725
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2004 AND VI 11 AND IP 9
Results: 6
1
2
Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 9, p. 613, doi. 10.1038/sj.cgt.7700729
- By:
- Publication type:
- Article
3
E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 9, p. 585, doi. 10.1038/sj.cgt.7700739
- By:
- Publication type:
- Article
4
Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 9, p. 625, doi. 10.1038/sj.cgt.7700740
- By:
- Publication type:
- Article
5
Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 9, p. 594, doi. 10.1038/sj.cgt.7700743
- By:
- Publication type:
- Article
6
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 9, p. 633, doi. 10.1038/sj.cgt.7700745
- By:
- Publication type:
- Article